Spero Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Spero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Spero Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Spero Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $672 | 458 | 1.47 |
| 2023-09-30 | $553 | 458 | 1.21 |
| 2023-06-30 | $664 | 458 | 1.45 |
| 2022-03-31 | $215k | 25k | 8.69 |
| 2021-12-31 | $308k | 19k | 15.99 |
| 2021-09-30 | $361k | 20k | 18.43 |
| 2021-06-30 | $259k | 19k | 13.95 |
| 2021-03-31 | $271k | 18k | 14.70 |
| 2020-12-31 | $373k | 19k | 19.41 |
| 2020-09-30 | $163k | 15k | 11.13 |
| 2020-06-30 | $243k | 18k | 13.55 |
| 2020-03-31 | $133k | 16k | 8.10 |
| 2019-12-31 | $148k | 15k | 9.62 |
| 2019-09-30 | $159k | 15k | 10.57 |
| 2019-06-30 | $156k | 14k | 11.50 |
| 2019-03-31 | $140k | 11k | 12.85 |
| 2018-12-31 | $62k | 10k | 6.19 |